Clinical Trial Update: Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing subcutaneous glucagon to the standard glucagon formulation; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia

Drugs mentioned

• Glucagon for Injection (glucagon)
• Glucagon for SC Injection (glucagon)

Snippet

Sponsor: Fresenius Kabi USA, LLC | Conditions: Hypoglycemia | Phase 1 | Status: COMPLETED